Search

Your search keyword '"Hsu, Fred"' showing total 161 results

Search Constraints

Start Over You searched for: Author "Hsu, Fred" Remove constraint Author: "Hsu, Fred"
161 results on '"Hsu, Fred"'

Search Results

1. Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMET

2. Upfront Versus Delayed Systemic Therapy in Patients With Oligometastatic Cancer Treated With SABR in the Phase 2 SABR-5 Trial

3. Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? a secondary analysis of the population-based phase II SABR-5 trial

8. 202 Safety and Efficacy of Fractionated Stereotactic Radiation Therapy for Pituitary Adenomas

9. 31 Prospective Longitudinal Assessment of Quality of Life After Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-Based SABR-5 Phase II Trial

10. 58 Should Organs at Risk (OARS) be Prioritized Over Target Volume Coverage in Stereotactic Ablative Radiotherapy (SABR) for Oligometastases? a Secondary Analysis of the Population-Based Phase II SABR-5 Trial

11. 59 Polymetastatic Recurrence-Free Survival in Patients with Repeat Oligometastases on the SABR-5 Trial

16. Treatment With Stereotactic Ablative Radiotherapy for Up to 5 Oligometastases in Patients With Cancer

22. 2: Population Based Phase II Trial of Stereotactic Ablative Radiotherapy (SABR) for Up to Five Oligometastases: Preliminary Results of the SABR-5 Trial

28. Additional file 1: of Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5

35. Patterns of spread and prognostic implications of lung cancer metastasis in an era of driver mutations.

36. Miliary metastases are associated with epidermal growth factor receptor mutations in non-small cell lung cancer: a population-based study.

41. 122: The Impact of a Central Nervous System Event on Cognitive Function After Radiation Treatment in Patients With One-Ten Brain Metastases

49. A phase II study of whole brain radiotherapy with simultaneous integrated boost using volumetric modulated arc therapy for 1 to 10 brain metastases.

Catalog

Books, media, physical & digital resources